These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 36406749)

  • 41. Gut dysbiosis and age-related neurological diseases in females.
    Korf JM; Ganesh BP; McCullough LD
    Neurobiol Dis; 2022 Jun; 168():105695. PubMed ID: 35307514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of gut microbiota on neuropsychiatric disorders.
    Cenit MC; Sanz Y; Codoñer-Franch P
    World J Gastroenterol; 2017 Aug; 23(30):5486-5498. PubMed ID: 28852308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utilizing the Gastrointestinal Microbiota to Modulate Cattle Health through the Microbiome-Gut-Organ Axes.
    Welch CB; Ryman VE; Pringle TD; Lourenco JM
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer's Disease.
    Borsom EM; Lee K; Cope EK
    Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33153085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fecal Microbiota Transplantation in Neurological Disorders.
    Vendrik KEW; Ooijevaar RE; de Jong PRC; Laman JD; van Oosten BW; van Hilten JJ; Ducarmon QR; Keller JJ; Kuijper EJ; Contarino MF
    Front Cell Infect Microbiol; 2020; 10():98. PubMed ID: 32266160
    [No Abstract]   [Full Text] [Related]  

  • 46. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
    Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
    Front Immunol; 2022; 13():937555. PubMed ID: 35812394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
    Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
    J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?
    Hill AE; Wade-Martins R; Burnet PWJ
    Front Neurosci; 2021; 15():708587. PubMed ID: 34512244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The microbiome-gut-brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications.
    Kundu S; Nayak S; Rakshit D; Singh T; Shukla R; Khatri DK; Mishra A
    Eur J Neurol; 2023 Nov; 30(11):3557-3567. PubMed ID: 36880679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases.
    Ghezzi L; Cantoni C; Rotondo E; Galimberti D
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
    Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
    Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
    Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
    BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases.
    Gates EJ; Bernath AK; Klegeris A
    Rev Neurosci; 2022 Oct; 33(7):767-787. PubMed ID: 35304983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modification of the gut microbiome to combat neurodegeneration.
    Sasmita AO
    Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
    De la Fuente M
    J Alzheimers Dis; 2021; 81(4):1345-1360. PubMed ID: 33935086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease.
    Askarova S; Umbayev B; Masoud AR; Kaiyrlykyzy A; Safarova Y; Tsoy A; Olzhayev F; Kushugulova A
    Front Cell Infect Microbiol; 2020; 10():104. PubMed ID: 32257964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut Microbiota and Neurologic Diseases and Injuries.
    Tyler Patterson T; Grandhi R
    Adv Exp Med Biol; 2020; 1238():73-91. PubMed ID: 32323181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent developments in understanding the role of the gut microbiota in brain health and disease.
    Sherwin E; Dinan TG; Cryan JF
    Ann N Y Acad Sci; 2018 May; 1420(1):5-25. PubMed ID: 28768369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.